January 2002

Current trials you may be interested in:

Riluzole drug trial

Riluzole has been approved in many countries worldwide for treatment of ALS. It has been conditionally approved in Canada pending results of this trial. The purpose of this trial is to establish whether Riluzole extends life expectancy.

Quality of life study

A series of questionnaires are given to the person with ALS and their caregiver to help determine the impact of enteral nutritional support on quality of life.

---